Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 7/20 | 0.63 |
| ▸ | ADRB1 | P08588 | 7/20 | 0.63 |
| ▸ | ADRB3 | P13945 | 7/20 | 0.63 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.57 |
| ▸ | LMNA | P02545 | 2/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | NPC1 | O15118 | 2/20 | 0.50 |
| ▸ | RAB9A | P51151 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | MLNR | O43193 | 1/20 | 0.45 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29613210 | 1.00 | ADRB2 (0.63) | ADRB2ADRB1ADRB3TDP1LMNA | |
| SCHEMBL17629572 | 1.00 | ADRB2 (0.63) | ADRB2ADRB1ADRB3TDP1LMNA | |
| SCHEMBL17629569 | 1.00 | ADRB2 (0.63) | ADRB2ADRB1ADRB3TDP1LMNA | |
| SCHEMBL12083435 | 0.91 | ADRB2 (0.68) | ADRB2ADRB1ADRB3TDP1LMNA | |
| SCHEMBL120454 | 0.90 | ALDH1A1 (0.61) | ADRB2ADRB1ADRB3ALDH1A1NPC1 | |
| SCHEMBL1031052 | 0.86 | ADRB2 (0.53) | ADRB2ADRB1ADRB3TDP1LMNA | |
| SCHEMBL24292233 | 0.85 | ADRB2 (0.66) | ADRB2ADRB1ADRB3TDP1LMNA | |
| SCHEMBL16088412 | 0.85 | ADRB2 (0.66) | ADRB2ADRB1ADRB3TDP1LMNA | |
| Glycerin SCHEMBL22574599 | 0.84 | TDP1 (0.63) | ADRB2ADRB1ADRB3TDP1LMNA | |
| Ethyl Salicylate SCHEMBL27636321 | 0.84 | TSHR (0.61) | ADRB2ADRB1ADRB3TDP1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 206 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115644177-B | Neutral peracetic acid disinfectant and preparation method thereof | 利康医药科技江苏有限公司 | 2024-03-15 | — | — | CN | claimed |
| CN-115644177-A | Neutral peroxyacetic acid disinfectant and preparation method thereof | 利康医药科技江苏有限公司 | 2023-01-31 | — | — | CN | claimed |
| EP-3197460-B1 | DERMOCOSMETIC OR PHARMACEUTICAL USE OF A COMPOSITION CONTAINING AT LEAST ONE INHIBITOR OF CERTAIN CHEMOKINES | GREENPHARMA SAS (FR) | 2022-04-20 | — | — | EP | claimed |
| CN-110746750-B | Heat-insulating anti-ultraviolet glass film and preparation method thereof | 湖南泉想湖智能科技有限公司 | 2021-12-17 | — | — | CN | claimed |
| CN-110746750-A | Heat-insulating anti-ultraviolet glass film and preparation method thereof | 宁波泰意德过滤技术有限公司 | 2020-02-04 | — | — | CN | claimed |
| US-20170281653-A1 | DERMOCOSMETIC OR PHARMACEUTICAL USE OF A COMPOSITION CONTAINING AT LEAST ONE INHIBITOR OF CERTAIN CHEMOKINES | GREENPHARMA SAS (FR) | 2017-10-05 | — | — | US | claimed |
| EP-3197460-A1 | DERMOCOSMETIC OR PHARMACEUTICAL USE OF A COMPOSITION CONTAINING AT LEAST ONE INHIBITOR OF CERTAIN CHEMOKINES | Greenpharma (FR) | 2017-08-02 | — | — | EP | claimed |
| WO-2016046456-A1 | DERMOCOSMETIC OR PHARMACEUTICAL USE OF A COMPOSITION CONTAINING AT LEAST ONE INHIBITOR OF CERTAIN CHEMOKINES | GREENPHARMA (FR) | 2016-03-31 | — | — | WO | claimed |
| CN-101448482-B | Glyceryl and glycol acid compounds | MARY KAY INC | 2013-10-09 | — | — | CN | claimed |
| US-7932417-B2 | Glyceryl and glycol acid compounds | MARY KAY INC. (US) | 2011-04-26 | — | — | US | claimed |
| CN-101448482-A | Glyceryl and glycol acid compounds | MARY KAY INC (US) | 2009-06-03 | — | — | CN | claimed |
| EP-2026753-A1 | GLYCERYL AND GLYCOL ACID COMPOUNDS | Mary Kay, Inc. (US) | 2009-02-25 | — | — | EP | claimed |
| WO-2007137128-A1 | GLYCERYL AND GLYCOL ACID COMPOUNDS | MARY KAY INC. (US) | 2007-11-29 | — | — | WO | claimed |
| US-20070269391-A1 | GLYCERYL AND GLYCOL ACID COMPOUNDS | MARY KAY, INC. (US) | 2007-11-22 | — | — | US | claimed |
| US-4016264-A | Wart treatment with phosphonoacetic acid or derivatives thereof | THE UNIVERSITY OF UTAH (US) | 1977-04-05 | — | — | US | claimed |
| US-20240099948-A1 | Compositions Comprising Silicon Dioxide-Based Particles Including One or More Agents | COLABS INT'L CORP. (US) | 2024-03-28 | — | — | US | disclosed |
| CN-115644177-B | Neutral peracetic acid disinfectant and preparation method thereof | 利康医药科技江苏有限公司 | 2024-03-15 | — | — | CN | disclosed |
| EP-0698393-A1 | SOLUBILIZING AGENT AND EXTERNAL PREPARATION CONTAINING THE SAME | Hisamitsu Pharmaceutical Co., Inc. (JP) | 1996-02-28 | — | — | EP | disclosed |
| US-4886843-A | CALCIUM HYDROXIDE CEMENT CHARACTERISTICS AND LIGHT CURE CHARACTERISTICS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1989-12-12 | — | — | US | disclosed |
| US-4229382-A | STABILIZERS FOR POLYOLEFINS | HOECHST AKTIENGESELLSCHAFT (DE) | 1980-10-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070269391-A1 | GLYCERYL AND GLYCOL ACID COMPOUNDS | GLA, GK, UNG | ADRB2 3838/4885ADRB1 3694/4885ADRB3 3232/4885 |
| US-20170281653-A1 | DERMOCOSMETIC OR PHARMACEUTICAL USE OF A COMPOSITION CONTAINING AT LEAST ONE INHIBITOR OF CERTAIN CHEMOKINES | CCL2, CCL11, CCL5 | ADRB2 2720/4885ADRB1 2665/4885ADRB3 2814/4885 |
| US-20240099948-A1 | Compositions Comprising Silicon Dioxide-Based Particles Including One or More Agents | MSN, LIPE, CUTA | ADRB2 4773/4885ADRB1 4731/4885ADRB3 4744/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.